Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?

Detalles Bibliográficos
Autores principales: Cooper, Lisa, Jose, Nadina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009564/
https://www.ncbi.nlm.nih.gov/pubmed/36923074
http://dx.doi.org/10.21037/atm-23-5
_version_ 1784906014657609728
author Cooper, Lisa
Jose, Nadina
author_facet Cooper, Lisa
Jose, Nadina
author_sort Cooper, Lisa
collection PubMed
description
format Online
Article
Text
id pubmed-10009564
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-100095642023-03-14 Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay? Cooper, Lisa Jose, Nadina Ann Transl Med Editorial AME Publishing Company 2023-02-06 2023-02-28 /pmc/articles/PMC10009564/ /pubmed/36923074 http://dx.doi.org/10.21037/atm-23-5 Text en 2023 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial
Cooper, Lisa
Jose, Nadina
Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?
title Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?
title_full Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?
title_fullStr Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?
title_full_unstemmed Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?
title_short Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?
title_sort despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (covid-19) pandemic, are decentralized clinical trial methods here to stay?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009564/
https://www.ncbi.nlm.nih.gov/pubmed/36923074
http://dx.doi.org/10.21037/atm-23-5
work_keys_str_mv AT cooperlisa despitenegativeperceptionsofclinicaltrialconductduringthecoronavirusdisease2019covid19pandemicaredecentralizedclinicaltrialmethodsheretostay
AT josenadina despitenegativeperceptionsofclinicaltrialconductduringthecoronavirusdisease2019covid19pandemicaredecentralizedclinicaltrialmethodsheretostay

Ejemplares similares